CliffBio
small molecule

OXYCONTIN

OXYCODONE HYDROCHLORIDE

Loss of exclusivityMarch 2030latest FDA-listed patent expiry
CompanyKNOA →View the full company profile on CliffBio

Drug detail

Brand nameOXYCONTIN
Active ingredientOXYCODONE HYDROCHLORIDE
Strength30MG
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
ModalitySmall molecule
FDA approvalApril 2010
Marketing statusRX

Listed patents

PatentExpiresType
8894987March 2030product
9492393August 2027use U-1556
9492391August 2027use U-1556
11304909August 2027use U-1556
9492392August 2027product
12246094August 2027product
9492389August 2027product
9775808August 2027product
9770416August 2027product
12280152August 2027product
9763933August 2027product
11304908August 2027product
11964056August 2027product
8808741August 2027use U-1556
8894988August 2027product

More from KNOA

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.

OXYCONTIN patent cliff — loss of exclusivity March 2030 | CliffBio